Supplementary Table. Baseline characteristics of the respondents.
Male/Female No(%) 7 (5.11.%)/130 (94.9%)
Age (mean±SD) 47.9±10.9
Disease duration (mean±SD) 5.9±4.8 Treatment
Artificial tears Ocular gels
Mouth topical ointments Pilocarpine
Hydroxychloroquine Methotrexate
Azathioprine Other * No treatment
119 (86.8%) 75 (54.7%) 30 (21.9%) 25 (18.2%) 94 (68.6%) 21 (15.3%) 6 (4.3%) 50 (36.5%) 4 (2.9%)
* Corticosteroids, Mycophenolate mofetil, Rituximab, Cyclosporine, Autologous serum eye drops, Bromhexine, Lacrimal punctum occlusion, Omega-3, Ursodeoxycholic acid.